As a Miami lawyer who sues prescription drug manufactures, I strongly urge the FDA to slow down and not allow innovation and corporate profit to outweigh consumer safety.
Read Whole Story
FRANKFURT, Aug 27 (Reuters) - Bayer said results from a late-stage clinical trial showed its anti-clotting pill Xarelto cut the risk of recurrence in ...
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.